Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-3-18
pubmed:abstractText
Mortality of 40% to 86% and good outcomes in only 13% to 21% of patients beg for treatment options for basilar occlusion. This study determined outcomes of patients with vertebrobasilar occlusion treated with mechanical embolus removal in cerebral ischemia (MERCI) retriever mechanical thrombectomy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1532-8511
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
17
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
55-7
pubmed:meshHeading
pubmed-meshheading:18346645-Adult, pubmed-meshheading:18346645-Aged, pubmed-meshheading:18346645-Aged, 80 and over, pubmed-meshheading:18346645-Equipment Design, pubmed-meshheading:18346645-Female, pubmed-meshheading:18346645-Fibrinolytic Agents, pubmed-meshheading:18346645-Humans, pubmed-meshheading:18346645-Infusions, Intravenous, pubmed-meshheading:18346645-Male, pubmed-meshheading:18346645-Middle Aged, pubmed-meshheading:18346645-Multicenter Studies as Topic, pubmed-meshheading:18346645-Randomized Controlled Trials as Topic, pubmed-meshheading:18346645-Recovery of Function, pubmed-meshheading:18346645-Severity of Illness Index, pubmed-meshheading:18346645-Stroke, pubmed-meshheading:18346645-Thrombectomy, pubmed-meshheading:18346645-Thrombolytic Therapy, pubmed-meshheading:18346645-Time Factors, pubmed-meshheading:18346645-Tissue Plasminogen Activator, pubmed-meshheading:18346645-Treatment Outcome, pubmed-meshheading:18346645-Vascular Patency, pubmed-meshheading:18346645-Vertebrobasilar Insufficiency
pubmed:articleTitle
Vertebrobasilar revascularization rates and outcomes in the MERCI and multi-MERCI trials.
pubmed:affiliation
Oregon Stroke Center, Oregon Health and Science University, Portland, Oregon 97239, USA. lutseph@ohsu.edu
pubmed:publicationType
Journal Article, Meta-Analysis